The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Deferred treatment as a viable option for selected patients with mantle cell lymphoma.
 
Oscar Calzada
No Relationships to Disclose
 
Jeffrey M. Switchenko
No Relationships to Disclose
 
Joseph J. Maly
No Relationships to Disclose
 
Kristie A. Blum
No Relationships to Disclose
 
Natalie Sophia Grover
No Relationships to Disclose
 
Stephanie Mathews
No Relationships to Disclose
 
Steven I. Park
Research Funding - Seagen; Teva
 
Max J Gordon
No Relationships to Disclose
 
Alexey Valeryevich Danilov
Honoraria - Dava Oncology
Consulting or Advisory Role - Pharmacyclics; Piramal Life Science
Research Funding - AstraZeneca; Piramal Life Science; Takeda
 
Christopher Flowers
Consulting or Advisory Role - OptumRx; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Jonathon Brett Cohen
Consulting or Advisory Role - Celgene; Millennium; Novartis; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Janssen; Novartis